Clinico-pathological feature of pilomyxoid astrocytomas: Three case reports

Neuropathology

Volumn 31, Issue 2, 2011, Pages 152-157

  Nagaishi, Masaya ^a   Yokoo, Hideaki ^a   Hirato, Junko ^a   Yoshimoto, Yuhei ^b   Nakazato, Yoichi ^a  

^a Departments of Human Pathology   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

MIB 1; Nestin; Pilocytic astrocytoma; Pilomyxoid astrocytoma; Prognosis

Indexed keywords

CARBOPLATIN; CD34 ANTIGEN; CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITHELIAL MEMBRANE ANTIGEN; ETOPOSIDE; GADOLINIUM; GLIAL FIBRILLARY ACIDIC PROTEIN; IFOSFAMIDE; KI 67 ANTIGEN; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NESTIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEIN P53; PROTEIN S 100;

ADULT; ARTICLE; ATAXIA; BASAL GANGLION; BRAIN BIOPSY; BRAIN RADIATION; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CEREBELLUM; CHILD; CLINICAL ARTICLE; CRANIOTOMY; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; FEMALE; HEADACHE; HEMIPARESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROCEPHALUS; IMMUNOHISTOCHEMISTRY; INTRACRANIAL HYPERTENSION; LIMB WEAKNESS; MALE; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PAPILLEDEMA; PILOCYTIC ASTROCYTOMA; PILOMYXOID ASTROCYTOMA; PINEAL BODY; PINEAL BODY TUMOR; POSTERIOR FOSSA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; RADIATION DOSE; SCHOOL CHILD; SURVIVAL RATE; THALAMUS; TREATMENT OUTCOME;

ADULT; ASTROCYTOMA; BASAL GANGLIA DISEASES; BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM RECURRENCE, LOCAL; PINEALOMA; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 79952713849     PISSN: 09196544     EISSN: 14401789     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2010.01143.x     Document Type: Article

References (30)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of Tumours of the Central Nervous System. Lyon: IARC, 2007.
2. Enting RH, van der Graaf WT, Kros JM, Heesters M, Metzemaekers J, den Dunnen W. Radiotherapy plus concomitant and adjuvant temozolomide for leptomeningeal pilomyxoid astrocytoma: a case study. J Neurooncol 2006; 80: 107-108.
3. Komotar RJ, Mocco J, Zacharia BE etal. Astrocytoma with pilomyxoid features presenting in an adult. Neuropathology 2006; 26: 89-93.
4. Nakazato Y, Sasaki A, Hirato J, Ishida Y. Immunohistochemical localization of neurofilament protein in neuronal degenerations. Acta Neuropathol 1984; 64: 30-36.
5. Yokoo H, Nobusawa S, Takebayashi H etal. Anti-human Olig2 antibody as a useful immunohistochemical marker of normal oligodendrocytes and gliomas. Am J Pathol 2004; 164: 1717-1725.
6. Reavey-Cantwell JF, Haroun RI, Zahurak M etal. The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature. J Neurooncol 2001; 55: 195-204.
7. Cao VT, Jung TY, Jung S etal. The correlation and prognostic significance of MGMT promoter methylation and MGMT protein in glioblastomas. Neurosurgery 2009; 65: 866-875.
8. Nakasu S, Fukami T, Baba K, Matsuda M. Immunohistochemical study for O6-methylguanine-DNA methyltransferase in the non-neoplastic and neoplastic components of gliomas. J Neurooncol 2004; 70: 333-340.
9. Tanaka G, Nakazato Y. Automatic quantification of the MIB-1 immunoreactivity in brain tumors. Int Congr Ser 2004; 1259: 15-19.
10. Torp SH. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies. Clin Neuropathol 2002; 21: 252-257.
11. Ganigi PM, Santosh V, Anandh B, Chandramouli BA, Sastry Kolluri VR. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients. Pediatr Neurosurg 2005; 41: 292-299.
12. Amatya VJ, Akazawa R, Sumimoto Y, Takeshima Y, Inai K. Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: comparative study with 11 pilocytic astrocytomas. Pathol Int 2009; 59: 80-85.
13. French PJ, Barlow A, Barlow P, Jampana RV, Stewart W. A case of pilomyxoid astrocytoma presenting with CSF rhinorrhoea in a 15-year-old. Br J Neurosurg 2009; 14: 1-3.
14. Hamada H, Kurimoto M, Hayashi N etal. Pilomyxoid astrocytoma in a patient presenting with fatal hemorrhage. Case report. J Neurosurg Pediatr 2008; 1: 244-246.
15. Sajadi A, Janzer RC, Lu TL, Duff JM. Pilomyxoid astrocytoma of the spinal cord in an adult. Acta Neurochir (Wien) 2008; 150: 729-731.
16. Tihan T, Fisher PG, Kepner JL etal. Pediatric astrocytomas with monomorphous pilomyxoid features and a less favorable outcome. J Neuropathol Exp Neurol 1999; 58: 1061-1068.
17. Tsugu H, Oshiro S, Yanai F etal. Management of pilomyxoid astrocytomas: our experience. Anticancer Res 2009; 29: 919-926.
18. Komotar RJ, Burger PC, Carson BS etal. Pilocytic and pilomyxoid hypothalamic/chiasmatic astrocytomas. Neurosurgery 2004; 54: 72-79.
19. Omura T, Nawashiro H, Osada H, Shima K, Tsuda H, Shinsuke A. Pilomyxoid astrocytoma of the fourth ventricle in an adult. Acta Neurochir (Wien) 2008; 150: 1203-1206.
20. Melendez B, Fiano C, Ruano Y, Hernandez-Moneo JL, Mollejo M, Martinez P. BCR gene disruption in a pilomyxoid astrocytoma. Neuropathology 2006; 26: 442-446.
21. Jeon YK, Cheon JE, Kim SK, Wang KC, Cho BK, Park SH. Clinicopathological features and global genomic copy number alterations of pilomyxoid astrocytoma in the hypothalamus/optic pathway: comparative analysis with pilocytic astrocytoma using array-based comparative genomic hybridization. Mod Pathol 2008; 21: 1345-1356.
22. Chikai K, Ohnishi A, Kato T etal. Clinico-pathological features of pilomyxoid astrocytoma of the optic pathway. Acta Neuropathol 2004; 108: 109-114.
23. Lieberman KA, Wasenko JJ, Schelper R, Swarnkar A, Chang JK, Rodziewicz GS. Tanycytomas: a newly characterized hypothalamic-suprasellar and ventricular tumor. AJNR Am J Neuroradiol 2003; 24: 1999-2004.
24. Ceppa EP, Bouffet E, Griebel R, Robinson C, Tihan T. The pilomyxoid astrocytoma and its relationship to pilocytic astrocytoma: report of a case and a critical review of the entity. J Neurooncol 2007; 81: 191-196.
25. Fernandez C, Figarella-Branger D, Girard N etal. Pilocytic astrocytomas in children: prognostic factors - a retrospective study of 80 cases. Neurosurgery 2003; 53: 544-553.
26. Gottfried ON, Fults DW, Townsend JJ, Couldwell WT. Spontaneous hemorrhage associated with a pilomyxoid astrocytoma. Case report. J Neurosurg 2003; 99: 416-420.
27. Clark GB, Henry JM, McKeever PE. Cerebral pilocytic astrocytoma. Cancer 1985; 56: 1128-1133.
28. Bowers DC, Gargan L, Kapur P etal. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. J Clin Oncol 2003; 21: 2968-2973.
29. Horbinski C, Hamilton RL, Lovell C, Burnham J, Pollack IF. Impact of morphology, MIB-1, p53 and MGMT on outcome in pilocytic astrocytomas. Brain Pathol 2010; 20: 581-588.
30. Zhang M, Song T, Yang L etal. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 2008; 27: 85.